Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PROCW | US
0
0%
Healthcare
Drug Manufacturers-Specialty & Generic
30/09/2023
11/09/2024
0.03
0.02
0.03
0.02
Procaps Group S.A. operates as an integrated healthcare and pharmaceutical company worldwide. The company formulates manufactures and markets branded prescription drugs in various therapeutic areas including feminine care products pain relief skin care digestive health growth and development cardiology vision care central nervous system and respiratory. It also provides drugs for hospital use such as antibiotic blood clot personal protective equipment immunosuppressant oncology and analgesics products. In addition the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately ten therapeutic areas including gastrointestinal skin care cough and cold analgesics urological vitamins minerals and supplements in the categories of antibiotics anti-infective anti-parasitic cardiovascular feminine care cutaneous antimycotic pain killers gastro intestinal hormonals metabolic endocrine nervous system ophthalmic osteoarticular respiratory diet supplements and vitamins and minerals. Further it provides blood glucose meters telemonitoring products oral anti-diabetics products cosmeceuticals insulin delivery systems and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg City Luxembourg.
View LessLow Market Beta (-0.4 to 0.8)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
503.2%1 month
471.4%3 months
282.3%6 months
306.3%-
-
-
-
-
-
-
-
57.06M
-
-
-
11.13
-63.70
7.30
37.37
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.02
Range1M
0.02
Range3M
0.03
Rel. volume
0.02
Price X volume
5.92
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Biofrontera Inc. Warrants | BFRIW | Drug Manufacturers-Specialty & Generic | 0.031 | 0 | -20.51% | n/a | 13.20% |
Alvotech Warrant | ALVOW | Drug Manufacturers-Specialty & Generic | 2.5 | 0 | n/a | -196.14% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.29 | 0 | 0.07% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | - | - | - |
Ent. to Revenue | - | - | - |
PE Ratio | - | 28.13 | - |
Price to Book | - | 11.07 | - |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 282.32 | - | Riskier |
Debt to Equity | - | -0.91 | - |
Debt to Assets | - | 0.45 | - |
Market Cap | - | - | - |